Modulating the cell attachment regulated apoptosis pathway

Description:
Biologics 
               Apoptosis - Cancer - Signal Transduction - Therapeutics


Compounds that regulate cell attachment apoptosis (anoikis) through the Bit1/AES pathway.

Lead Inventor
Erkki Ruoslahti, M.D., Ph.D.
Ruoslahti lab homepage

Selected References
List of references via Pubmed

Patent Information
Click here for patent


Full title: Methods of Modulating Cell Death Based on the BIT-1/AES Regulatory Pathway
U.S. Patent/Application #: 7,393,653
Priority date: 9-6-2002
Foreign filing: no
Burnham ID: 02-039

Status
Available for license


 









Patent Information:
Category(s):
Biologicals
For Information, Contact:
Glenn Dourado, MSc., MBA
Sanford-Burnham Medical Research Institute
gdourado@sanfordburnham.org
Inventors:
Erkki Ruoslahti, M.D., Ph.D.
Keywords:
Apoptosis
Cancer
Signal Transduction
Therapeutics